DK1455770T3 - Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser - Google Patents
Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelserInfo
- Publication number
- DK1455770T3 DK1455770T3 DK02784195T DK02784195T DK1455770T3 DK 1455770 T3 DK1455770 T3 DK 1455770T3 DK 02784195 T DK02784195 T DK 02784195T DK 02784195 T DK02784195 T DK 02784195T DK 1455770 T3 DK1455770 T3 DK 1455770T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- tic disorders
- uptake inhibitors
- norepinephrine uptake
- norepinephrine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33449401P | 2001-11-30 | 2001-11-30 | |
PCT/US2002/033628 WO2003047560A1 (en) | 2001-11-30 | 2002-11-12 | Use of norepinephrine reuptake inhibitors for the treatment of tic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1455770T3 true DK1455770T3 (da) | 2007-10-08 |
Family
ID=23307469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02784195T DK1455770T3 (da) | 2001-11-30 | 2002-11-12 | Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser |
Country Status (12)
Country | Link |
---|---|
US (2) | US20050014843A1 (da) |
EP (1) | EP1455770B1 (da) |
JP (1) | JP2005515199A (da) |
KR (1) | KR20050044604A (da) |
AT (1) | ATE365035T1 (da) |
AU (1) | AU2002347984A1 (da) |
CA (1) | CA2466649A1 (da) |
DE (1) | DE60220825T2 (da) |
DK (1) | DK1455770T3 (da) |
ES (1) | ES2287338T3 (da) |
PT (1) | PT1455770E (da) |
WO (1) | WO2003047560A1 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6602911B2 (en) * | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
US20050096395A1 (en) * | 2002-02-12 | 2005-05-05 | Rao Srinivas G. | Methods of treating attention deficit/hyperactivity disorder (adhd) |
KR20060121178A (ko) * | 2003-12-12 | 2006-11-28 | 일라이 릴리 앤드 캄파니 | 일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제 |
US20090048243A1 (en) * | 2005-01-18 | 2009-02-19 | Mitsubishi Pharma Corporation | Therapeutic agent for attention-deficit hyperactivity disorder |
US7994220B2 (en) * | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
US20080031932A1 (en) * | 2006-08-04 | 2008-02-07 | Watson Laboratories, Inc. | Transdermal atomoxetine formulations and associated methods |
KR102096165B1 (ko) | 2018-05-03 | 2020-04-01 | 노충구 | 틱 장애 개선 및 치료 효과를 가지는 약학적 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
IL56369A (en) * | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
US5281624A (en) * | 1991-09-27 | 1994-01-25 | Eli Lilly And Company | N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof |
US6323242B1 (en) * | 1998-12-02 | 2001-11-27 | Peter Sterling Mueller | Treatment of disorders secondary to organic impairments |
DE60022916T2 (de) * | 1999-07-01 | 2006-07-06 | Pharmacia & Upjohn Co. Llc, Kalamazoo | Reboxetin zur Behandlung von peripheren Neuropathien |
NZ520975A (en) * | 2000-02-24 | 2004-03-26 | Upjohn Co | New drug combinations containing a norepinephrine reuptake inhibitor and an antimuscarinic agent for treating nervous system disorders |
WO2002053140A2 (en) * | 2001-01-02 | 2002-07-11 | Pharmacia & Upjohn Company | New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
-
2002
- 2002-11-12 US US10/495,303 patent/US20050014843A1/en not_active Abandoned
- 2002-11-12 PT PT02784195T patent/PT1455770E/pt unknown
- 2002-11-12 KR KR1020047008010A patent/KR20050044604A/ko not_active Application Discontinuation
- 2002-11-12 AU AU2002347984A patent/AU2002347984A1/en not_active Abandoned
- 2002-11-12 EP EP02784195A patent/EP1455770B1/en not_active Expired - Lifetime
- 2002-11-12 CA CA002466649A patent/CA2466649A1/en not_active Abandoned
- 2002-11-12 DE DE60220825T patent/DE60220825T2/de not_active Expired - Fee Related
- 2002-11-12 JP JP2003548816A patent/JP2005515199A/ja active Pending
- 2002-11-12 AT AT02784195T patent/ATE365035T1/de not_active IP Right Cessation
- 2002-11-12 ES ES02784195T patent/ES2287338T3/es not_active Expired - Lifetime
- 2002-11-12 DK DK02784195T patent/DK1455770T3/da active
- 2002-11-12 WO PCT/US2002/033628 patent/WO2003047560A1/en active IP Right Grant
-
2008
- 2008-04-01 US US12/060,318 patent/US20080200555A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2287338T3 (es) | 2007-12-16 |
ATE365035T1 (de) | 2007-07-15 |
DE60220825D1 (de) | 2007-08-02 |
US20050014843A1 (en) | 2005-01-20 |
WO2003047560A1 (en) | 2003-06-12 |
CA2466649A1 (en) | 2003-06-12 |
JP2005515199A (ja) | 2005-05-26 |
KR20050044604A (ko) | 2005-05-12 |
US20080200555A1 (en) | 2008-08-21 |
EP1455770A1 (en) | 2004-09-15 |
EP1455770B1 (en) | 2007-06-20 |
AU2002347984A1 (en) | 2003-06-17 |
PT1455770E (pt) | 2007-09-06 |
DE60220825T2 (de) | 2008-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1651161T3 (da) | Farmaceutiske præparater og fremgangsmåder til at fremme sårheling | |
BR0312785A (pt) | Tratamento de desordens relacionadas a tnf(alfa) | |
DK1420801T3 (da) | Anvendelse af fucaner til behandling af adhæsioner, arthritis og psoreasis | |
DK1809280T3 (da) | Mitotiske kinesininhibitorer og fremgangsmåder til anvendelse deraf | |
EA200602241A1 (ru) | Замещённые индазолы, композиции, содержащие указанные индазолы, способ их получения и применение | |
NO20061092L (no) | Heteroarvlaminosulfonvlfenvl-derivater for anvendelse som natrium- eller kalslumkanalblokkere i behandlingen av smerte | |
CY1105082T1 (el) | Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας | |
TR200000755T2 (tr) | Karşıt olma-karşı gelme bozukluğunun tedavisi. | |
DK0971713T3 (da) | Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser | |
ATE322258T1 (de) | Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren | |
NO20054371L (no) | Somatostatin-dopamin kimaere analoger | |
NO20053042L (no) | Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi. | |
NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
DE60108857D1 (de) | Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren | |
DK1315506T3 (da) | Phospholipidderivater af valproinsyre og blandinger deraf | |
DK1456380T3 (da) | SMAD7-inhibitorer til behandling af CNS-sygdomme | |
NO20076186L (no) | Mitotiske kinesininhibitorer og fremgangsmater for anvendelse derav | |
ATE399557T1 (de) | Selektive norepinephrin-wiederaufnahmehemmer zur behandlung von hitzewallungen | |
NO20025405D0 (no) | Modulatorer for TNF-alfa-signalisering | |
UY28344A1 (es) | Nuevos compuestos | |
MY136367A (en) | Treatment of cognitive failure | |
DE60329326D1 (de) | Tace inhibitoren | |
ATE410235T1 (de) | Behandlung von ballastwasser | |
NO20061425L (no) | Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin | |
DK1455770T3 (da) | Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser |